Tag Archives: Venture Capital

Welcome to San Diego and to the 2016 BIO World Congress!

BIO World Congress

Welcome to San Diego and to the 13th Annual BIO World Congress on Industrial Biotechnology. This is actually our first time hosting this event in San Diego and in California…and that is a testament to this region’s commitment, vision and focus on fostering and growing its industrial biotechnology sector. We have a great turnout this year,  with industry leaders from over 50 countries…making this event, once again, the world’s largest industrial biotechnology event of the year. I Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , ,

Opportunities for VC Funding Abound in San Francisco

hyde pier

If you’re an emerging biotech company looking for your first round of funding, the BIO Investor Forum in San Francisco may be your best bet to connect with the right investors. Small biotech startups are finding massive success in the Bay Area as venture capitalists turn their gaze from social networking and tech companies towards the biotechnology industry. Investors are realizing that the rewards for supporting early stage biotechs are potentially greater than for supporting Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

The Bio Report: What a Decade of Investment Tells Us About the Health of Biotech

Emerging Therapeutic Company Investment and Deal Trends

In this podcast, The Bio Report’s Daniel Levine interviews BIO’s Dave Thomas on the recent release of a new BIO Industry Analysis report – Emerging Therapeutic Company Investment and Deal Trends – highlighting ten years (2005-2014) of biotechnology funding and deal making across five areas: venture capital, IPOs, follow-on public offerings, licensing, and acquisitions. The report also offers a first-time look at the degree of collaboration across the industry’s clinical pipeline. Some of the key findings Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Life Science Leader Asks: What Areas Are Often Overlooked by Academics Turned Biotech Entrepreneurs?

Life Science Leader

In my third installment of a four-part series interviewing Peter Young, executive-in-residence with A.M. Pappas & Associates, he shared missteps made by academics aspiring to become entrepreneurs and also offered up some advice on partnering with VCs. Check out my interview, which will include lessons that won’t be a part of his 2015 BIO International Convention session, Inventing Your Own Hub: Evolving Institutional Models for Translational Medicine, (June 16, 3:30 p.m.-4:45 p.m., room 105AB) Here is Part 1, Read More >

Business and Investments, Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , ,

State of the Industry for Emerging Therapeutic Companies

Emerging Therapeutic Company Investment and Deal Trends

Emerging therapeutic companies are at their strongest point in a decade. In our new report on investment and deal trends, the BIO Industry Analysis team shows how this segment within the biotech industry has been faring over the last 10 years. The annual aggregate totals show that for almost every funding or deal activity analyzed, 2014 was the peak year of the last decade. A strong public market, a revitalized private funding environment, and a Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,